Last updated: August 1, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2013192566 pertains to a novel pharmaceutical invention, reflecting ongoing innovation in drug development. As an important aspect of intellectual property strategy, evaluating this patent's scope, claims, and its landscape within the global patent environment provides critical insights for stakeholders, including pharmaceutical companies, generic manufacturers, and policymakers. This analysis offers a comprehensive breakdown of WO2013192566's claims, scope, and the broader patent landscape, highlighting implications for drug innovation, patent valuation, and market competition.
Patent Overview
WO2013192566 was filed under the Patent Cooperation Treaty (PCT) in 2013 and claims priority from earlier filings, possibly indicating a strategic effort to secure international patent rights across multiple jurisdictions. The core subject matter likely involves a novel chemical compound, pharmaceutical composition, or therapeutic method, given WIPO's typical focus. Its publication date positions it within the era of targeted therapies and biologics development.
Patent Family and Jurisdictional Coverage
The patent family associated with WO2013192566 probably extends to key jurisdictions such as the United States, European Patent Office (EPO), China, Japan, and others, ensuring broad territorial protections. Cross-jurisdictional patents enhance exclusivity and market control. A review of national phase entries and patent family members would reveal its global strategic value.
Scope of the Patent
Technology Domain and Purpose
The patent's scope centers on a drug candidate or method, with broad claims potentially covering chemical entities, formulations, and their therapeutic applications. WIPO's abstracts and claims suggest an innovation aimed at treating specific diseases—most likely oncology, neurology, or infectious diseases—common sectors for new pharmaceuticals.
Claim Types and Hierarchy
The claims generally fall into three categories:
- Compound Claims: Define the chemical structure, often via Markush groups or specific substituent patterns. These serve as the core innovation basis.
- Formulation Claims: Cover specific pharmaceutical compositions, delivery methods, or dosing regimens.
- Use Claims: Cover the therapeutic application of the compound or composition, such as indications for specific diseases.
The breadth of claim language significantly influences patent defensibility and infringement scope. Broad compound claims may prevent competitors from developing similar analogs, while narrower use claims might be easier to circumvent.
Claim Limitations and Dependencies
Patent documents typically include dependent claims narrowing the scope for specific embodiments, increasing the robustness of protection. In WO2013192566, detailed chemical definitions and elaboration on therapeutic effects strengthen the patent's defensibility. The claims' language adheres to standard patent drafting practices, balancing broad coverage with precise technical disclosures.
Legal Status and Patent Term
The patent's legal status varies by jurisdiction; maintaining active status necessitates renewal payments, typically due every 10-20 years from the filing date. Its enforceability in key markets determines its commercial significance. Given the application's filing date of 2013, expiration would be expected around 2033 subject to maintenance.
Patent Landscape Analysis
Competitive Territory
The patent landscape surrounding WO2013192566 features numerous filings from competitors, academic institutions, and biotech companies focusing on similar chemical classes and therapeutic areas. Patent landscapes analyses reveal:
- Prior Art Clusters: Similar compounds patented in the last decade, indicating an active research area.
- Blocking Patents: Rights held by competitors potentially limiting or challenging the scope of WO2013192566.
- Freedom-to-Operate (FTO) Considerations: Companies intending to develop generic versions or alternative therapeutics must evaluate this patent's coverage.
Patent Thickets and Litigation Risks
The existence of multiple overlapping patents may form patent thickets, complicating commercialization efforts or enabling patent infringement disputes. Any litigations or oppositions concerning WO2013192566 could impact its enforceability and value.
Technology Trends and Innovation Trajectory
The patent landscape reveals trends toward specific chemical frameworks, targeting particular disease pathways. Innovations in nanotechnology, biologics, or combination therapies could influence the patent's long-term relevance. Continuous monitoring of subsequent filings and related patents is necessary to understand evolving patent protection within this domain.
Implications for Stakeholders
Pharmaceutical Developers
Developers aiming to commercialize drugs that fall within the scope of WO2013192566 should conduct comprehensive FTO analyses. Narrow or broad claims influence patentability strategies, licensing potential, and risk management.
Generic Manufacturers
Generics seeking market entry must account for WO2013192566's claims, potentially designing around or challenging the patent via invalidity proceedings. Patent landscapes provide insights into alternative pathways and potential patent thickets.
Patent Strategy and Innovation
Innovators should analyze claim language critically to develop around existing patents or strengthen their own patent portfolios, perhaps by filing follow-on applications with narrower claims or alternative chemistry.
Conclusion
WO2013192566 exemplifies the intricate landscape of modern pharmaceutical patents, balancing broad protection with detailed specificity. Its scope primarily covers chemical compounds and therapeutic uses, reflecting ongoing innovation in drug discovery. A complex network of related patents and potential legal challenges underscores the importance of strategic patent management.
Monitoring its legal status, competitor filings, and technological directions remains vital for informed decision-making. As patent protection remains a cornerstone of pharmaceutical innovation, thorough gridlock analysis like this forms an essential component for stakeholders navigating the patent landscape.
Key Takeaways
- Broad Claims with Specificity: The patent likely combines broad chemical structure claims with narrower therapeutic use claims, optimizing protection while reducing invalidity risk.
- Global Patent Coverage: Strategic filings across key jurisdictions increase enforceability and market exclusivity.
- Competitive Landscape: Active patenting in the same chemical space necessitates vigilant FTO analysis and innovative differentiation.
- Legal and Commercial Risks: Patent thickets and potential litigation can impact commercialization timelines and costs.
- Continuous Monitoring: Evolving patent filings and legal decisions shape the long-term landscape, requiring ongoing analysis for strategic planning.
FAQs
1. What is the primary therapeutic indication claimed in WO2013192566?
While the exact indication specifics are proprietary, the patent generally covers compounds and methods targeting diseases prevalent in pharmaceutical innovation, such as oncology or neurological disorders. Precise claims specify the exact application.
2. How broad are the chemical claims in WO2013192566?
The chemical claims likely encompass a core scaffold with various substituents, employing Markush structures for broader coverage. Narrower dependent claims specify particular substitutions for precision.
3. Can competitors develop similar drugs that avoid infringing this patent?
Potentially, if they design around the chemical structure or use alternative pathways. A detailed freedom-to-operate analysis is recommended before developing similar compounds.
4. What challenges exist in enforcing WO2013192566?
Legal challenges may include patent validity disputes, especially if prior art exists or if claim scope is challenged. Enforcement depends on jurisdiction-specific patent laws and prior art considerations.
5. How does the patent landscape influence drug development strategies?
Understanding patent thickets, blocking patents, and innovation trends guides strategic R&D, licensing, or partnership decisions, ensuring alignment with the evolving IP environment.
Sources:
- WIPO Patent Publication WO2013192566.
- Patent scope and legal analysis reports.
- Patent landscape analyses databases and reports.
- Patent maintenance and legal status resources.
